Achieving better AAV vector productivity and product quality
The BioInsights Podcast
More Info
The BioInsights Podcast
Achieving better AAV vector productivity and product quality
Aug 05, 2022 Season 1 Episode 10
BioInsights

Transient transfection of plasmids into suspension HEK293 cells is still the most commonly used method for the production of recombinant adeno-associated virus (rAAV) gene therapies – in this episode, Diane Golebiowski and Marissa Stanvick discuss ways to optimize that process.